Decitabine

In the US, Decitabine (decitabine systemic) is a member of the drug class antimetabolites and is used to treat Myelodysplastic Syndrome.

US matches:

• Decitabine


• Decitabine Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01BC08

CAS registry number (Chemical Abstracts Service)

0002353-33-5

Chemical Formula

C8-H12-N4-O4

Molecular Weight

228

Therapeutic Category

Antineoplastic agent, antimetabolite

Chemical Names

1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)- (USAN)

4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one (WHO)

4-amino-1-(2-desoxy-beta-D-erythro-pentofuranosyl)-s-triazin-2(1H)-on (IUPAC)

4-Amino-1-(2-desoxy-beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-on

5-aza-2'-deoxycytidine

s-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-

Foreign Names

• Decitabinum (Latin)
• Decitabin (German)
• Decitabine (French)
• Decitabina (Spanish)

Generic Names

• Decitabine (OS: BAN, USAN)
• 5-azaCdR (IS)
• 5-aza-DCyd (IS)
• d-AZc (IS)
• Dezocitidine (IS)
• NSC-127716 (IS: Pharmachemie)

Brand Name

• Dacogen
  Eisai, United States

International Drug Name Search

Glossary

BAN	British Approved Name
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.